Status:
COMPLETED
The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
IBA, Germany
Hospimed, Netherland
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Implantation of fiducial markers in the prostate and daily check of the positioning during radiotherapy based on the implanted fiducial markers
Eligibility Criteria
Inclusion
- histological proven adenocarcinoma of the prostate
- T1-T4 tumors
- Radiotherapy as primary therapy +/- androgen deprivation
- Presence of an intraprostatic lesion (IPL) on MRI/MRS
- Presence of an intraprostatic lesion (IPL) on ultrasound
- WHO 0-2
Exclusion
- Other primary tumor, except non-melanoma skin cancer
- No written informed consent
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00841685
Start Date
December 1 2008
End Date
May 1 2012
Last Update
January 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000